[{"Assets_0_Q3_USD":118196000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-123151000.0,"NetIncomeLoss_1_Q3_USD":-41866000.0,"NetIncomeLoss_3_Q3_USD":-134994000.0,"StockholdersEquity_0_Q3_USD":40053000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20171106"}]